Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland
About this trial
The primary aim is to perform the largest study worldwide to evaluate novel biochemical and electrocardiographic signatures alone as well as in combination with the standard 12-lead exercise ECG in the detection of exercise-induced myocardial ischemia (diagnostic endpoint). The secondary aim is to evaluate these innovative tools in the risk prediction for the occurrence of cardiovascular death and acute myocardial infarction during long-term follow-up.
Eligibility criteria
Qualifiers
Patients presenting with suspected exercise-induced myocardial ischemia referred for rest/ergometry myocardial perfusion SPECT
Disqualifiers
Age < 18 years
Pregnancy
Unable or unwilling to give informed consent
Symptoms at rest or minor exertion
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1University Hospital Basel4031, Basel Switzerland
Sponsors and collaborators
University Hospital, Basel, Switzerland
Lead sponsor
Source ClinicalTrials.gov